Cencora OUTPH Videos

1. Cell And Gene Therapies – U.S. Payer Trends 5/20/2026

   Gain insights from U.S. payer interviews covering coverage processes, evidence requirements, and engagement strategies to accelerate market access from late-stage development through commercialization.

2. The Transformative Potential Of AI In HEOR And Market Access 5/20/2026

   HEOR teams are under pressure to move faster without sacrificing rigor. Discover how AI accelerates evidence synthesis, fills data gaps, and supports living models that meet HTA transparency standards.

3. The Evolving Policy Landscape: U.S. And EU Pricing And Access 5/20/2026

   U.S. and EU policy shifts are reshaping pricing, access, and launch strategy. Hear expert analysis on IRA, MFN, 340B, EU HTA Regulation, and the Biotech Act to stay ahead of 2025-2026 changes.

4. Foundations And Implications For International Reference Pricing 5/14/2026

   Reforms like the U.S. Most Favored Nation model are intensifying pressure on global launch strategies. Understand the tactics that protect value while expanding access.

5. The Growing Role Of Real-World Evidence 5/14/2026

   Regulators and HTA bodies are raising the bar on real-world evidence. Understand how JCAs, oncology registries, and EHR data are redefining what credible RWE looks like, and how to meet agency expectations.

6. Integrated Quality, Regulatory, And Safety Services 3/18/2026

   A single-vendor model for quality, regulatory, and safety services provides consistent project management and cost-effective scalability. Hear how integrated solutions support market entry and growth.

7. Understanding PRCI And Its Requirements 2/18/2026

   Navigating Health Canada's clinical information disclosure process takes real precision and preparation. Ensure your submission stays compliant, on schedule, and ready for review.

8. Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order Management 6/16/2025

   Streamline complex cell and gene therapy logistics with an integrated platform that connects manufacturers with vital services, providing full visibility and control for a more efficient and successful patient journey.

9. Crafting Scalable Solutions For Maximum Reach And Success 6/12/2025

   Is your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.

10. Maximizing Impact: Strategies For Building Robust Patient Support Programs 6/12/2025

    Panelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.